14 results on '"Hogan W"'
Search Results
2. Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
3. Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies
4. A phase-2 trial of low-dose pomalidomide in myelofibrosis
5. JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
6. Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
7. Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation
8. Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
9. Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib
10. Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation
11. Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies
12. A phase-2 trial of low-dose pomalidomide in myelofibrosis
13. JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
14. Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.